The medical condition or reason for a Sexual Health and HIV Episode.
The following codes are used within the data set:
| Diagnosis and/or treatment of infection or disease | |
| A1 | Primary syphilis |
| A2 | Secondary syphilis |
| A3 | Early latent syphilis |
| A4 | Cardiovascular syphilis |
| A5 | Neurosyphilis |
| A6 | All other late and latent syphilis |
| A7A | Congenital syphilis |
| A10 | Ocular syphilis |
| A11 | Otosyphilis |
| B | Gonorrhoea |
| C1 | Chancroid |
| C2 | Lymphogranuloma venereum (LGV) |
| C3 | Donovanosis |
| C4 | Chlamydial infection |
| C4N | Non-specific genital infection (NSGI) |
| C5A | Pelvic inflammatory disease (PID) and epididymitis |
| C5B | Ophthalmia neonatorum |
| C6A | Trichomoniasis |
| C6B | Anaerobic/Bacterial vaginosis and anaerobic balanitis |
| C6C | Other vaginosis/vaginitis/balanitis |
| C7A | Anogenital candidosis |
| C8 | Scabies |
| C9 | Pediculosis pubis |
| C10A | Anogenital Herpes simplex: First episode |
| C10B | Anogenital Herpes simplex: Recurrent episode |
| C11A | Anogenital warts infection: First episode |
| C11D | Anogenital warts infection: Recurrent episode |
| C12 | Molluscum contagiosum |
| C13 | Viral hepatitis B (HbsAg positive): First diagnosis |
| C14 | Viral hepatitis C: First diagnosis |
| C15 | Viral hepatitis A: Acute infection |
| C16 | Mycoplasma genitalium |
| D2A | Urinary Tract Infection |
| D2B | Other conditions requiring treatment at Level 3 Genitourinary Medicine Services |
| H | HIV positive - Previously Diagnosed |
| H1 | New HIV diagnosis |
| H1A | New HIV diagnosis: Acute |
| H1B | New HIV diagnosis: Late infection (AIDS defined) |
| H2 | Attendance for HIV-related care |
| P4A | Cervical cytology: minor abnormality |
| P4B | Cervical cytology: major abnormality |
| Sexual Health Services Provided To record PATIENTS receiving Sexual Health Services or undergoing tests. | |
| T1 | Chlamydia test |
| T2 | Chlamydia and gonorrhoea tests |
| T3 | Chlamydia, gonorrhoea and syphilis tests |
| T4 | Chlamydia, gonnorrhoea, syphilis and HIV antibody tests |
| T5 | Herpes Simplex Virus (HSV) Test |
| T6 | Hepatitis A/B/C Test |
| TS | Microscopy |
| TT | 3 Site Testing (chlamydia and gonorrhoea) |
| T7 | Syphilis and HIV Testing |
| T8 | Self sampling (urinalysis/swabs) without Health Care worker (HCW) consultation |
| T9 | STI testing not required/appropriate |
| T10 | Rapid testing (STI and/or HIV) |
| T11 | Chlamydia test declined |
| T12 | Mycoplasma genitalium test |
| O20 | Hepatitis A vaccination: 1st dose |
| O21 | Hepatitis A vaccination: Subsequent dose |
| O22 | Hepatitis A immune |
| O23 | Partner notification related attendance: Hepatitis A contact |
| O31 | PrEP eligibility criteria 1: MSM/transgender woman |
| O32 | PrEP eligibility criteria 2: HIV positive partner |
| O33 | PrEP eligibility criteria 3: Other high risk |
| O41 | PrEP regimen: Starting or continuing daily Prep |
| O42 | PrEP regimen: Starting or continuing event based Prep |
| O43 | PrEP regimen: Continued through other source |
| O44 | PrEP regimen: Offered and declined |
| O45 | PrEP regimen: Stopped |
| O51 | PrEP prescription: 30 tablets |
| O52 | PrEP prescription: 60 tablets |
| O53 | PrEP prescription: 90 tablets |
| O60 | PrEP patient characteristic: Transgender |
| P1A | Human Immunodeficiency Virus (HIV) antibody test (no sexual health screen) |
| P1B | Human Immunodeficiency Virus (HIV) antibody test offered and refused |
| P1C | HIV test inappropriate |
| P2A | Hepatitis B vaccination: 1st dose |
| P2B | Hepatitis B vaccination: 2nd dose |
| P2C | Hepatitis B vaccination: 3rd dose |
| P2D | Hepatitis B vaccination: 4th dose |
| P2E | Hepatitis B vaccination: Booster |
| P2I | Hepatitis B immune |
| P3 | CONTRACEPTION and family planning advice (excluding condom provision) |
| P4 | Cervical cytology done |
| REF1 | Referral from Chlamydia Screening Programme |
| REF2 | Referral to a Level 3 Genitourinary Medicine Service |
| REF3 | Referral from home testing/sampling service |
| SG1 | Shigella flexneri (group B) |
| SG2 | Shigella sonnei (group D) |
| SG3 | Shigella other/unspecified |
| SRH | Sexual and Reproductive Health PATIENT |
| W1 | HPV vaccination: 1st dose |
| W2 | HPV vaccination: 2nd dose |
| W3 | HPV vaccination: 3rd dose |
| W4 | HPV vaccination: offered and declined |
| W5 | HPV vaccination: previously received in full |
| PN | Partner notification initiated related attendance |
| PNC | Partner notification related attendance: Chlamydia contact |
| PNG | Partner notification related attendance: Gonorrhoea contact |
| PNH | Partner notification related attendance: HIV contact |
| PNN | Partner notification related attendance: Non-specific genital infection contact |
| PNP | Partner notification related attendance: PID/Epididymitis contact |
| PNS | Partner notification related attendance: Syphilis contact |
| PNT | Partner notification related attendance: Trichomoniasis contact |
| PR1 | Pregnant 1-12 weeks |
| PR2 | Pregnant 13-28 weeks |
| PR3 | Pregnant 29-40 weeks |
| PEPS | Post exposure prophylaxis after sexual exposure (PEPSE) |
| D3 | Other Sexual Health and HIV Episodes not requiring treatment |
| O11-O99 | Research/New/Urgent reporting (Retired 01 October 2018) |
| 40 | Sexual Assault (Acute presentation) |
| 41 | Sexual Assault (Non - acute presentation) |
| Findings | |
| CSE1 | Child sexual exploitation : concerns raised at internal assessment |
| CSE2 | Child sexual exploitation : concerns raised with internal safeguarding professionals |
| CSE3 | Child sexual exploitation : referred to external safeguarding professionals |
| DV | Concern of domestic violence (or abuse) |
| FGM | Female genital mutilation (of any type) |
| Special PATIENT Groups To record additional information on certain PATIENT groups receiving Sexual Health Services or undergoing tests. Codes to be reported separately at each FIRST ATTENDANCE. | |
| Z | Prisoner |
| SW | Sex Worker |
| Suffixes to Codes To record additional information about the PATIENT’s presentation or a Sexual Health Service given. This information may be collected through the use of suffixes which can be applied to the SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE. Where appropriate, multiple suffixes can be used on the same SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE. The suffixes and the codes with which they can be used are given below. These codes are appended to the SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE. | |
| R | Rectal infection |
| O | Pharyngeal infection |
| X | Previously diagnosed elsewhere |
| M | Medication given |
| Q | Quadrivalent HPV vaccine |
| Permissible Code Permutations Using Suffixes | |
| A - Syphilis | |
| A1X | Primary syphilis - previously diagnosed elsewhere |
| A2X | Secondary syphilis - previously diagnosed elsewhere |
| A3X | Early latent syphilis - previously diagnosed elsewhere |
| A4X | Cardiovascular syphilis - previously diagnosed elsewhere |
| A5X | Neurosyphillis syphilis - previously diagnosed elsewhere |
| A6X | All other late and latent syphilis - previously diagnosed elsewhere |
| A7AX | Congenital syphilis - previously diagnosed elsewhere |
| B - Gonorrhoea | |
| BR | Gonorrhoea - rectal infection |
| BO | Gonorrhoea - pharayngeal infection |
| BX | Gonorrhoea - previously diagnosed elsewhere |
| BM | Gonorrhoea - medication given |
| BRX | Gonorrhoea - rectal infection, previously diagnosed elsewhere |
| BRM | Gonorrhoea - rectal infection, medication given |
| BOX | Gonorrhoea - pharayngeal infection, previously diagnosed elsewhere |
| BOM | Gonorrhoea - pharayngeal infection, medication given |
| C4 - Chlamydia | |
| C4R | Chlamydia - rectal infection |
| C4O | Chlamydia - pharayngeal infection |
| C4X | Chlamydia - previously diagnosed elsewhere |
| C4M | Chlamydia - medication given |
| C4RX | Chlamydia - rectal infection, previously diagnosed elsewhere |
| C4RM | Chlamydia - rectal infection, medication given |
| C4OX | Chlamydia - pharayngeal infection, previously diagnosed elsewhere |
| C4OM | Chlamydia - pharayngeal infection, medication given |
| C2 - Lymphogranuloma (LGV) | |
| C2R | Lymphogranuloma venereum (LGV) - Rectal infection |
| C2O | Lymphogranuloma venereum (LGV) - Pharayngeal infection |
| C4N - NSGI | |
| C4NR | Non-specific genital infection (NSGI) - rectal infection (proctitis) |
| C6A - Trichomoniasis | |
| C6AX | Trichomoniasis - previously diagnosed elsewhere |
| H1 - New HIV diagnosis | |
| H1X | New HIV diagnosis - previously diagnosed elsewhere |
| H1A - New HIV diagnosis: acute | |
| H1AX | New HIV diagnosis: acute - previously diagnosed elsewhere |
| H1B - HIV diagnosis: late (AIDS defined) | |
| H1BX | New HIV diagnosis: late (AIDS defined) - previously diagnosed elsewhere |
| C10A - Anogenital Herpes simplex: first episode | |
| C10AM | Anogenital Herpes simplex: first episode - medication given |
| C10B - Anogenital Herpes simplex: recurrent episode | |
| C10BM | Anogenital Herpes simplex: recurrent episode - medication given |
| C11A - Anogenital warts infection: first episode | |
| C11AM | Anogenital warts infection: first episode - medication given |
| C11D - Anogenital warts infection: recurrent episode | |
| C11DM | Anogenital warts infection: recurrent episode - medication given |
| W1 - HPV Vaccination: 1st dose | |
| W1Q | HPV Vaccination: 1st dose - quadrivalent vaccine |
| W2 - HPV Vaccination: 2nd dose | |
| W2Q | HPV Vaccination: 2nd dose - quadrivalent vaccine |
| W3 - HPV Vaccination: 3rd dose | |
| W3Q | HPV Vaccination: 3rd dose - quadrivalent vaccine |
This attribute is also known by these names:
| Context | Alias |
|---|---|
| formerly | GENITOURINARY EPISODE TYPE |
| plural | SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPES |
